how many people use glp 1 drugs GLP-1 trends 2025: real-world data, patient outcomes & future therapies Here's how many Americans say

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved a new indication for Wegovy (semaglutide) to reduce the risk of overweight and obese adults suffering serious heart problems or strokes.

Learn about the Zepbound blindness lawsuit, including NAION and other eye side effects, and read about a study linking GLP-1 RAs to severe vision problems.

The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss.

Learn how different GLP-1 medications work, how they differ for weight loss vs diabetes and why dual agonists like tirzepatide stand out.

Learn about GLP-1 receptor agonists (exenatide, liraglutide, semaglutide, tirzepatide) their mechanism, dosing, cautions, side effects, and interactions

The GLP-1 receptor assay is a powerful tool for the identification of GLP-1 receptor agonists aimed at treating obesity and type 2 diabetes